The Friedreich’s Ataxia treatment was approved by HSE Senior Management last month.
A Longford-Westmeath TD says the October 1st deadline for reimbursement of Skyclarys must be met.
Skyclarys was approved for reimbursement by the HSE Senior Management Team on 25th August for treating patients with the rare genetic condition, Friedreich’s Ataxia.
The product's supplier, Biogen, says stock will be available later this month.
Fine Gael's Micheál Carrigy says he's determind for the rollout to be in place in time for those who need it:
Ploughing 2026 Live Day Three: EU Agri Commissoner Coming To Offaly
IFA Wants EU To "Get Its House In Order" Before Adding Canada As Associate Member
Ploughing 2026 Day Two: As It Happened
There Are Very Strict Rules When It Comes To International Sport - Tanaiste
Terminating A Pregnancy Is Not An Easy Or Quick Decision - Sorca Clarke
Three Day Abortion Waiting Period Under Scrutiny In Leinster House
An Post Opens Recruitment For 1,600 Christmas Workers
Initiative Tackling Drug Related Intimidation Gets Funding Boost